Serial 97331599
Live / Registered — Registered (as of 11 Nov 2025)
What this means for you
Registered since 11 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97331599
- Registration number
- 8023907
- Mark type
- Design / logo
- Filed
- 25 Mar 2022
- Published for opposition
- 30 Jan 2024
- Registered
- 11 Nov 2025
- Attorney of record
- Robin Lightner Maisashvili
Goods and services
- Class 035 — Advertising and business services: Promoting collaboration within the scientific, research, pharmaceutical, and medical communities to achieve advances in healthcare, including to accelerate the development and use of immunotherapy in treatment of disease
- Class 036 — Insurance and financial services: Charitable fundraising services
- Class 041 — Education and entertainment services: Educational services, namely, conducting programs, seminars and lectures in the fields of science and medicine relating to immunobiology, immunotherapy, wellness, cancer and diseases
- Class 042 — Scientific and technological services: Medical research services; medical research, development, technical design, testing, and analysis services in the field of immunobiology, immunotherapy, antibodies, and oncology; consulting services in the fields of immunobiology, immunotherapy, antibodies, and oncology research, development, testing, analysis and data; medical research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; medical research services in the field of immune repertoire analysis and the genome; scientific research in the fields of immunobiology, immunotherapy, antibodies and oncology; biological research; laboratory research services in the fields of immunobiology, immunotherapy, antibodies, oncology, and cellular engineering; medical laboratory services; providing information on medical and scientific research in the field of immunobiology and immunotherapy; medical and scientific research for others in the field of stem cell research, cancer, immunobiology and immunotherapy; compiling data for research purposes in the field of medical science and medical consultancy; medical and scientific research liaison services, namely, consulting in the field of scientific research pertaining to clinical trials in the fields of health care, medicine, immunobiology, immunotherapy, pharmacology and biotechnology; collection and management of medical and scientific data for research purposes in the field of medical and scientific research; pharmaceutical research services; pharmaceutical research services relating to cancer
- Class 044 — Medical, beauty and agricultural services: Medical services; Medical services relating to cancer; providing medical information; providing health information in the field of immunobiology, immunotherapy, oncology and diseases; providing a web site featuring medical information; providing a web site featuring health information in the field of immunobiology, immunotherapy, oncology and diseases; providing medical information, consultancy and advisory services; providing information on cancer treatment; providing medical information to patients and medical professionals in the field of immunotherapy and cancer treatment
Owner
- The Board of Regents of the University of Texas System, Austin, TX, US
- The Board of Regents of the University of Texas System, Austin, TX, US
- The Board of Regents of the University of Texas System, Austin, TX, US
Prosecution history
- 11 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 21 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 05 May 2025 — USE AMENDMENT FILED
- 02 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 May 2025 — TEAS STATEMENT OF USE RECEIVED
- 27 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Mar 2025 — SOU EXTENSION 2 GRANTED
- 26 Mar 2025 — SOU EXTENSION 2 FILED
- 26 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Sept 2024 — SOU EXTENSION 1 GRANTED
- 25 Sept 2024 — SOU EXTENSION 1 FILED